Ginkgo Bioworks Holdings Inc

DNA

Company Profile

  • Business description

    Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

  • Contact

    27 Drydock Avenue
    8th Floor
    BostonMA02210
    USA

    T: +1 877 422-5362

    https://www.ginkgobioworks.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    485

Stocks News & Analysis

stocks

Beaten down real estate share receives legal blow

Real estate share remains cheap despite losing airport legal battle.
stocks

OpenAI joins the mega-AI lab IPO race, but timing is uncertain

The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.
stocks

What happens if Tesla and SpaceX merge?

We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,006.1029.100.32%
CAC 408,350.87150.081.83%
DAX 4024,635.30425.591.76%
Dow JONES (US)51,202.26353.510.70%
FTSE 10010,471.72167.841.63%
HKSE24,718.10468.811.93%
NASDAQ25,888.8479.180.31%
Nikkei 22566,020.041,802.772.81%
NZX 50 Index13,393.87191.711.45%
S&P 5007,431.4637.160.50%
S&P/ASX 2008,804.0030.500.35%
SSE Composite Index4,031.5144.501.12%

Market Movers